Aim of the [Merck-Afrigen Biologics] collaboration is to develop mRNA platform technology, scale up and troubleshoot challenges in mRNA process optimization Merck, a leading science and technology company, announced that its Life Science...

The Extension Funds Nucleai to Advance Its First-in-Class Spatial AI Biomarker in Active Clinical Enrollment Investment Expands Deployments of AI-Powered Spatial Biomarker Technology, Strengthening Companion Diagnostics for ADCs,...

Pfizer Says Its COVID-19 Pill Reduces Death, Hospitalization Risk by 89%; Will Submit for FDA Approval Pfizer says that its COVID-19 pill reduced the risk of hospitalization or death by 89 percent in a clinical trial involving adults “at...

PM and health minister reach agreement with drug company for ‘tens of thousands of doses’; initial data shows almost 90% efficacy Pfizer has pledged a shipment of its experimental antiviral COVID-19 pill to Israel, according to a Saturday...

By MATTHEW PERRONE  November 5, 2021 WASHINGTON (AP) — Pfizer Inc. said Friday that its experimental antiviral pill for COVID-19 cut rates of hospitalization and death by nearly 90% in high-risk adults, as the drugmaker joined the race for...

Alongside genomics, Tissue Phenomics™ is a key driver in the growth of personalized medicine and the improvement of patient lives. The unique ability of Tissue Phenomics’ to extract detailed quantitative data from tissue images and...